A phase 1 study to assess the pharmacokinetics of AZD9977 administered alone and in combination with itraconazole in healthy volunteers

Trial Identifier: D6401C00003
Sponsor: AstraZeneca
NCTID:: NCT03843060
Start Date: February 2019
Primary Completion Date: April 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English language

Trial Locations

Country Location
United States of America, MD Baltimore, MD, United States of America, 21225